Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

Core Viewpoint - Milestone Scientific Inc. announces the retirement of CEO Arjan Haverhals effective December 31, 2024, while he will continue to serve as a director and consultant to support the leadership transition [1][2]. Leadership Transition - Neal Goldman, Chairman of the Board, will assume the role of Interim CEO following Haverhals' departure, with the Board actively seeking a permanent CEO to lead the company’s growth and commercialization efforts for the CompuFlo® Epidural System [3][4]. CEO Contributions - Haverhals has had a distinguished career of over 30 years in the medical device and pharmaceutical industries, contributing significantly to the financial and operational stability of Milestone Scientific [2][5]. - Under his leadership, the company achieved a granted Medicare Part B Physician payment rate for the CompuFlo® Epidural System, which is a significant milestone for its commercialization [5]. Company Overview - Milestone Scientific Inc. focuses on developing innovative injection technologies aimed at enhancing patient comfort and safety through its proprietary DPS Dynamic Pressure Sensing Technology® [6].